Traphaco JSC (TRA) - Net Assets
Based on the latest financial reports, Traphaco JSC (TRA) has net assets worth ₫1.57 Trillion VND (≈ $59.73 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫2.41 Trillion ≈ $91.56 Million USD) and total liabilities (₫837.63 Billion ≈ $31.83 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Traphaco JSC PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₫1.57 Trillion |
| % of Total Assets | 65.24% |
| Annual Growth Rate | 7.09% |
| 5-Year Change | 33.04% |
| 10-Year Change | N/A |
| Growth Volatility | 2.44 |
Traphaco JSC - Net Assets Trend (2019–2025)
This chart illustrates how Traphaco JSC's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Traphaco JSC stock valuation.
Annual Net Assets for Traphaco JSC (2019–2025)
The table below shows the annual net assets of Traphaco JSC from 2019 to 2025. Also explore net asset momentum of Traphaco JSC to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₫1.69 Trillion ≈ $64.07 Million |
+10.02% |
| 2024-12-31 | ₫1.53 Trillion ≈ $58.23 Million |
+2.93% |
| 2023-12-31 | ₫1.49 Trillion ≈ $56.58 Million |
+7.86% |
| 2022-12-31 | ₫1.38 Trillion ≈ $52.45 Million |
+8.92% |
| 2021-12-31 | ₫1.27 Trillion ≈ $48.16 Million |
+8.11% |
| 2020-12-31 | ₫1.17 Trillion ≈ $44.55 Million |
+4.87% |
| 2019-12-31 | ₫1.12 Trillion ≈ $42.48 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Traphaco JSC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 27.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₫343.05 Billion | 22.09% |
| Other Components | ₫1.21 Trillion | 77.91% |
| Total Equity | ₫1.55 Trillion | 100.00% |
Traphaco JSC Competitors by Market Cap
The table below lists competitors of Traphaco JSC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NFON AG
XETRA:NFN
|
$58.28 Million |
|
Helbor Empreendimentos S.A
SA:HBOR3
|
$58.32 Million |
|
Cayson Acquisition Corp Ordinary shares
NASDAQ:CAPN
|
$58.33 Million |
|
Hil Industries Bhd
KLSE:8443
|
$58.34 Million |
|
Saga Communications Inc
NASDAQ:SGA
|
$58.23 Million |
|
Seresco S.A.
MC:SCO
|
$58.23 Million |
|
Cassava Sciences Inc
NASDAQ:SAVA
|
$58.21 Million |
|
Chongqing Iron & Steel Company Limited
F:CGP
|
$58.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Traphaco JSC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,419,377,490,742 to 1,552,811,502,775, a change of 133,434,012,033 (9.4%).
- Net income of 249,654,508,066 contributed positively to equity growth.
- Dividend payments of 167,119,550,776 reduced retained earnings.
- Other factors increased equity by 50,899,054,743.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₫249.65 Billion | +16.08% |
| Dividends Paid | ₫167.12 Billion | -10.76% |
| Other Changes | ₫50.90 Billion | +3.28% |
| Total Change | ₫- | 9.40% |
Book Value vs Market Value Analysis
This analysis compares Traphaco JSC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.49x to 0.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ₫24884.31 | ₫37000.00 | x |
| 2020-12-31 | ₫26037.58 | ₫37000.00 | x |
| 2021-12-31 | ₫28182.60 | ₫37000.00 | x |
| 2022-12-31 | ₫30762.03 | ₫37000.00 | x |
| 2023-12-31 | ₫33276.39 | ₫37000.00 | x |
| 2024-12-31 | ₫34242.68 | ₫37000.00 | x |
| 2025-12-31 | ₫37461.79 | ₫37000.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Traphaco JSC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.08%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.40%
- • Asset Turnover: 1.14x
- • Equity Multiplier: 1.50x
- Recent ROE (16.08%) is below the historical average (18.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 14.87% | 8.97% | 1.09x | 1.52x | ₫50.28 Billion |
| 2020 | 18.14% | 10.26% | 1.16x | 1.53x | ₫87.86 Billion |
| 2021 | 20.68% | 11.18% | 1.27x | 1.46x | ₫124.77 Billion |
| 2022 | 21.11% | 11.22% | 1.32x | 1.42x | ₫141.63 Billion |
| 2023 | 19.09% | 11.45% | 1.08x | 1.54x | ₫125.32 Billion |
| 2024 | 16.84% | 10.18% | 1.08x | 1.53x | ₫97.08 Billion |
| 2025 | 16.08% | 9.40% | 1.14x | 1.50x | ₫94.37 Billion |
Industry Comparison
This section compares Traphaco JSC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $1,973,634,646,199
- Average return on equity (ROE) among peers: 16.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Traphaco JSC (TRA) | ₫1.57 Trillion | 14.87% | 0.53x | $58.27 Million |
| Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) | $988.63 Billion | 15.97% | 0.45x | $168.37 Million |
| DHG Pharmaceutical JSC (DHG) | $4.09 Trillion | 19.02% | 0.46x | $449.56 Million |
| DOMESCO Medical Import Export JSC (DMC) | $1.25 Trillion | 18.58% | 0.22x | $77.19 Million |
| Imexpharm Corp (IMP) | $1.56 Trillion | 10.42% | 0.18x | $220.01 Million |
About Traphaco JSC
Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases,… Read more